Figure 1From: Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndromeFlow diagram for the phase 1 component of the START trial. Abbreviations are as follows: acute respiratory distress syndrome, ARDS; adverse event, AE; bone marrow transplantation, BMT; Data Safety Monitoring Board, DSMB; positive end-expiratory pressure, PEEP.Back to article page